These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Effectiveness of Tailored Dietary Counseling in Treating Malnourished Outpatients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Trial. Nguyen HT; Pavey TG; Collins PF; Nguyen NV; Pham TD; Gallegos D J Acad Nutr Diet; 2020 May; 120(5):778-791.e1. PubMed ID: 31786177 [TBL] [Abstract][Full Text] [Related]
8. Influence of a nutritional intervention on dietary intake and quality of life in cancer patients: a randomized controlled trial. Uster A; Ruefenacht U; Ruehlin M; Pless M; Siano M; Haefner M; Imoberdorf R; Ballmer PE Nutrition; 2013; 29(11-12):1342-9. PubMed ID: 24103511 [TBL] [Abstract][Full Text] [Related]
9. Family dietary coaching to improve nutritional intakes and body weight control: a randomized controlled trial. Paineau DL; Beaufils F; Boulier A; Cassuto DA; Chwalow J; Combris P; Couet C; Jouret B; Lafay L; Laville M; Mahe S; Ricour C; Romon M; Simon C; Tauber M; Valensi P; Chapalain V; Zourabichvili O; Bornet F Arch Pediatr Adolesc Med; 2008 Jan; 162(1):34-43. PubMed ID: 18180410 [TBL] [Abstract][Full Text] [Related]
10. A prospective study of nutritional status in immunoglobulin light chain amyloidosis. Sattianayagam PT; Lane T; Fox Z; Petrie A; Gibbs SD; Pinney JH; Risom SS; Rowczenio DM; Wechalekar AD; Lachmann HJ; Gilbertson JA; Hawkins PN; Gillmore JD Haematologica; 2013 Jan; 98(1):136-40. PubMed ID: 22983575 [TBL] [Abstract][Full Text] [Related]
11. Focused review on nutritional status of patients with immunoglobulin light chain amyloidosis. Grigoletti SS; Zuchinali P; Lemieux-Blanchard É; Béchard S; Lemieux B; Ribeiro PAB; Tournoux F Curr Probl Cancer; 2022 Jun; 46(3):100833. PubMed ID: 35101705 [TBL] [Abstract][Full Text] [Related]
12. Nutrition support using the American Dietetic Association medical nutrition therapy protocol for radiation oncology patients improves dietary intake compared with standard practice. Isenring EA; Bauer JD; Capra S J Am Diet Assoc; 2007 Mar; 107(3):404-12. PubMed ID: 17324657 [TBL] [Abstract][Full Text] [Related]
13. High-dose melphalan versus melphalan plus dexamethasone for AL amyloidosis. Jaccard A; Moreau P; Leblond V; Leleu X; Benboubker L; Hermine O; Recher C; Asli B; Lioure B; Royer B; Jardin F; Bridoux F; Grosbois B; Jaubert J; Piette JC; Ronco P; Quet F; Cogne M; Fermand JP; N Engl J Med; 2007 Sep; 357(11):1083-93. PubMed ID: 17855669 [TBL] [Abstract][Full Text] [Related]
14. Hematology patient reported symptom screen to assess quality of life for AL amyloidosis. Warsame R; Kumar SK; Gertz MA; Lacy MQ; Buadi FK; Hayman SR; Leung N; Dingli D; Lust JA; Lin Y; Russell S; Kapoor P; Go RS; Kourelis T; Gonsalves W; Zeldenrust SR; Kyle RA; Vincent Rajkumar S; Zemla T; Sloan J; Dispenzieri A Am J Hematol; 2017 May; 92(5):435-440. PubMed ID: 28181278 [TBL] [Abstract][Full Text] [Related]
15. Risk-adapted autologous stem cell transplantation with adjuvant dexamethasone +/- thalidomide for systemic light-chain amyloidosis: results of a phase II trial. Cohen AD; Zhou P; Chou J; Teruya-Feldstein J; Reich L; Hassoun H; Levine B; Filippa DA; Riedel E; Kewalramani T; Stubblefield MD; Fleisher M; Nimer S; Comenzo RL Br J Haematol; 2007 Oct; 139(2):224-33. PubMed ID: 17897298 [TBL] [Abstract][Full Text] [Related]
16. Depression and anxiety in patients with AL amyloidosis as assessed by the SF-36 questionnaire: experience in 1226 patients Shu J; Lo S; Phillips M; Sun F; Seldin DC; Berenbaum I; Berk JL; Sanchorawala V Amyloid; 2016 Sep; 23(3):188-193. PubMed ID: 27460276 [TBL] [Abstract][Full Text] [Related]
18. Current and emerging views and treatments of systemic immunoglobulin light-chain (Al) amyloidosis. Comenzo RL Contrib Nephrol; 2007; 153():195-210. PubMed ID: 17075231 [TBL] [Abstract][Full Text] [Related]
19. Impact of nutrition on outcome: a prospective randomized controlled trial in patients with head and neck cancer undergoing radiotherapy. Ravasco P; Monteiro-Grillo I; Marques Vidal P; Camilo ME Head Neck; 2005 Aug; 27(8):659-68. PubMed ID: 15920748 [TBL] [Abstract][Full Text] [Related]
20. A phase II trial of lenalidomide, dexamethasone and cyclophosphamide for newly diagnosed patients with systemic immunoglobulin light chain amyloidosis. Cibeira MT; Oriol A; Lahuerta JJ; Mateos MV; de la Rubia J; Hernández MT; Granell M; Fernández de Larrea C; San Miguel JF; Bladé J; Br J Haematol; 2015 Sep; 170(6):804-13. PubMed ID: 25974382 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]